Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies.
暂无分享,去创建一个
J. Trojanowski | M. Grossman | Douglas Galasko | A. Siderowf | I. Litvan | D. Weintraub | D. Irwin | D. Pizzo | Eddie B. Lee | R. Rissman | L. Hansen | L. Giannini | A. Hiniker | D. Coughlin | Claire Peterson | Claire S. Peterson | Sanaz Arezoumandan | Yongya Kim | Lucia A. A. Giannini | M. Grossman
[1] M. Jinzaki,et al. Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies , 2021, Brain communications.
[2] D. Dickson,et al. Deep learning‐based model for diagnosing Alzheimer's disease and tauopathies , 2021, Neuropathology and applied neurobiology.
[3] T. Montine,et al. Semantic fluency and processing speed are reduced in non-cognitively impaired participants with Parkinson’s disease , 2021, Journal of clinical and experimental neuropsychology.
[4] A. Murzin,et al. Structure-based classification of tauopathies , 2021, Nature.
[5] L. Tian,et al. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer’s Disease Pathology , 2021, Journal of Alzheimer's disease : JAD.
[6] J. Trojanowski,et al. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology , 2021, Acta neuropathologica communications.
[7] J. Trojanowski,et al. Cognitive Profile and Markers of Alzheimer Disease–Type Pathology in Patients With Lewy Body Dementias , 2021, Neurology.
[8] D. Dickson,et al. Deep Learning-Based Image Classification in Differentiating Tufted Astrocytes, Astrocytic Plaques, and Neuritic Plaques. , 2021, Journal of neuropathology and experimental neurology.
[9] T. Yen,et al. 18F-THK5351 PET imaging in patients with progressive supranuclear palsy: associations with core domains and diagnostic certainty , 2020, Scientific Reports.
[10] J. Trojanowski,et al. Tau pathology associates with in vivo cortical thinning in Lewy body disorders , 2020, Annals of clinical and translational neurology.
[11] J. Trojanowski,et al. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer’s disease , 2020, Neuropathology and applied neurobiology.
[12] Alzheimer's Disease Neuroimaging Initiative,et al. Multimodal in vivo and postmortem assessments of tau in Lewy body disorders , 2020, Neurobiology of Aging.
[13] John L. Robinson,et al. Distribution patterns of tau pathology in progressive supranuclear palsy , 2020, Acta Neuropathologica.
[14] Val J Lowe,et al. Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. , 2020, JAMA neurology.
[15] A. Murzin,et al. Novel tau filament fold in corticobasal degeneration , 2020, Nature.
[16] Mari Yoshida,et al. Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration , 2020, Neuropathology : official journal of the Japanese Society of Neuropathology.
[17] D. Irwin,et al. Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases , 2020, Movement disorders : official journal of the Movement Disorder Society.
[18] Rene L. Utianski,et al. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants , 2019, NeuroImage: Clinical.
[19] L. Walker. Glial tauopathy: Neurons optional? , 2019, The Journal of experimental medicine.
[20] J. Trojanowski,et al. Human tau pathology transmits glial tau aggregates in the absence of neuronal tau , 2019, The Journal of experimental medicine.
[21] David T. Jones,et al. Tau-positron emission tomography correlates with neuropathology findings , 2019, Alzheimer's & Dementia.
[22] J. Trojanowski,et al. Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies. , 2019, Radiology.
[23] Jesse A. Brown,et al. Evidence of corticofugal tau spreading in patients with frontotemporal dementia , 2019, Acta Neuropathologica.
[24] B. Cullen,et al. Neuropathology of dementia in patients with Parkinson’s disease: a systematic review of autopsy studies , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.
[25] Clifford R. Jack,et al. Multimodal neuroimaging relationships in progressive supranuclear palsy. , 2019, Parkinsonism & related disorders.
[26] G. Schellenberg,et al. TRANSMISSION OF TAUOPATHY STRAINS IS INDEPENDENT OF THEIR ISOFORM COMPOSITION , 2019, Alzheimer's & Dementia.
[27] I. Ferrer,et al. Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies , 2019, Front. Aging Neurosci..
[28] J. Trojanowski,et al. Divergent patterns of TDP‐43 and tau pathologies in primary progressive aphasia , 2019, Annals of neurology.
[29] C. Jack,et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report , 2019, Brain : a journal of neurology.
[30] J. Trojanowski,et al. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders , 2018, Annals of neurology.
[31] Fabio Sambataro,et al. Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data , 2018, Front. Aging Neurosci..
[32] B. Miller,et al. Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders , 2018, JAMA.
[33] Janna H. Neltner,et al. Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques. , 2018, Journal of Alzheimer's disease : JAD.
[34] John L. Robinson,et al. Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain , 2018, Acta Neuropathologica Communications.
[35] J. Trojanowski,et al. CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders , 2018, Neurology.
[36] E. Londos,et al. 18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies , 2018, Scientific Reports.
[37] Hanna Cho,et al. Distinct patterns of amyloid‐dependent tau accumulation in Lewy body diseases , 2018, Movement disorders : official journal of the Movement Disorder Society.
[38] Alan J. Thomas,et al. Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.
[39] Murray Grossman,et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.
[40] F. Gage,et al. Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology , 2017, The Journal of Neuroscience.
[41] T. Montine,et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis , 2017, The Lancet Neurology.
[42] Peter Bankhead,et al. QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.
[43] C. Rowe,et al. Tau imaging with [18F]THK‐5351 in progressive supranuclear palsy , 2017, European journal of neurology.
[44] David T. Jones,et al. AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies , 2016, Annals of neurology.
[45] Keith A. Johnson,et al. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases. , 2016, JAMA neurology.
[46] C. Adler,et al. Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects. , 2016, Journal of Parkinson's disease.
[47] M. Schain,et al. Increased basal ganglia binding of 18 F‐AV‐1451 in patients with progressive supranuclear palsy , 2016, Movement disorders : official journal of the Movement Disorder Society.
[48] D. Galasko,et al. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies. , 2016, Parkinsonism & related disorders.
[49] N. Schuff,et al. Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study , 2016, PloS one.
[50] David Neil Manners,et al. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease , 2016, NeuroImage: Clinical.
[51] John Q. Trojanowski,et al. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease , 2016, Alzheimer's & Dementia.
[52] J. Trojanowski,et al. Deep clinical and neuropathological phenotyping of Pick disease , 2016, Annals of neurology.
[53] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[54] Alan J. Thomas,et al. Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes , 2015, Acta Neuropathologica.
[55] E. Tolosa,et al. The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases , 2014, Movement disorders : official journal of the Movement Disorder Society.
[56] T. Hortobágyi,et al. Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias , 2014, Brain pathology.
[57] Murray Grossman,et al. A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank , 2014, Alzheimer's & Dementia.
[58] H. Shill,et al. Concomitant pathologies among a spectrum of parkinsonian disorders. , 2014, Parkinsonism & related disorders.
[59] Mark Hallett,et al. Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.
[60] Ela Patel,et al. Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes. , 2012, Journal of neuropathology and experimental neurology.
[61] John L. Robinson,et al. Neuropathologic substrates of Parkinson disease dementia , 2012, Annals of neurology.
[62] P. Pal,et al. In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS , 2012, Neuroradiology.
[63] B. Boeve,et al. Rapid eye movement sleep behavior disorder and subtypes in autopsy‐confirmed dementia with Lewy bodies , 2012, Movement disorders : official journal of the Movement Disorder Society.
[64] Clifford R. Jack,et al. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. , 2011, Parkinsonism & related disorders.
[65] J. Trojanowski,et al. Clinicopathological correlations in corticobasal degeneration , 2011, Annals of neurology.
[66] Murray Grossman,et al. Building an integrated neurodegenerative disease database at an academic health center , 2011, Alzheimer's & Dementia.
[67] Dennis W. Dickson,et al. Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau) , 2011, Journal of Molecular Neuroscience.
[68] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[69] Constantinos Kallis,et al. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? , 2011, Brain : a journal of neurology.
[70] D. Dickson,et al. Neuropathology of variants of progressive supranuclear palsy. , 2010, Current opinion in neurology.
[71] C. Jack,et al. Dementia with Lewy bodies and Alzheimer disease , 2010, Neurology.
[72] Dag Aarsland,et al. Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer Pathology , 2009, Alzheimer disease and associated disorders.
[73] K. Jellinger,et al. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease , 2008, Acta Neuropathologica.
[74] G. Halliday,et al. The progression of pathology in longitudinally followed patients with Parkinson’s disease , 2008, Acta Neuropathologica.
[75] E. Tolosa,et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[76] A. Lees,et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. , 2007, Brain : a journal of neurology.
[77] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[78] Joseph James Duffy,et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP , 2006, Neurology.
[79] S Minoshima,et al. Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.
[80] H. Braak,et al. Staging of Sporadic Parkinson Disease-Related α-Synuclein Pathology: Inter- and Intra-Rater Reliability , 2005, Journal of neuropathology and experimental neurology.
[81] E B Larson,et al. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both , 2005, Neurology.
[82] P. Lantos,et al. Overlap between neurodegenerative disorders , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.
[83] Masanori Kato,et al. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer’s disease , 2004, Acta Neuropathologica.
[84] R. Armstrong,et al. Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis , 2003, Histopathology.
[85] D. Jeste,et al. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies , 2003, Neurology.
[86] A. Lees,et al. Dementia with Lewy bodies from the perspective of tauopathy , 2003, Acta Neuropathologica.
[87] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[88] Toshiki Nakai,et al. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies , 2002, Journal of the Neurological Sciences.
[89] K. Jellinger,et al. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease , 2002, Journal of Neural Transmission.
[90] I Litvan,et al. Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.
[91] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[92] J. Trojanowski,et al. Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia. , 2018, Brain : a journal of neurology.
[93] Charles Duyckaerts,et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.
[94] James T Becker,et al. Research evaluation and prospective diagnosis of dementia with Lewy bodies. , 2002, Archives of neurology.
[95] H. Chui,et al. Neuropathologic Diagnosis of Alzheimer Disease: Interrater Reliability in the Assessment of Senile Plaques and Neurofibrillary Tangles , 1993, Alzheimer disease and associated disorders.